sexta-feira, 13 de novembro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· June 29, 2026

Energy ETFs VDE and EMLP Differ on Cost and Approach

View original at nasdaq.com
Energy ETFs VDE and EMLP Differ on Cost and Approach Key Points Vanguard Energy ETF offers a significantly lower expense ratio than First Trust North American Energy Infrastructure Fund Vanguard Energy ETF has outperformed on a 1-year total return basis but has experienced a deeper historical maximum drawdown First Tru…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • EMLP provides heavier exposure to utilities (54%) while VDE is almost entirely concentrated in the energy sector (approximately 99%)

    60% confidence
  • EMLP has generated a 10-year total return of 165% with a CAGR of 10.3%

    60% confidence
  • VDE is significantly more affordable than EMLP, with an expense ratio of 0.09% compared to 0.95% charged by First Trust

    60% confidence
  • VDE's top holdings — ExxonMobil, Chevron, and ConocoPhillips — are vertically integrated companies involved in every aspect of energy discovery and delivery, from exploration and recovery through transportation, refining, and consumer sales

    60% confidence
  • Beta is calculated from five-year monthly returns relative to the S&P 500; VDE beta is 0.42 and EMLP beta is 0.56

    60% confidence
  • VDE may be favored by investors seeking traditional energy sector exposure at a reasonable cost; investors willing to pay higher fees may favor EMLP for its track record of delivering higher long-term returns

    60% confidence
  • Both VDE and EMLP have substantially underperformed the S&P 500 index over the last decade; the S&P 500 generated total returns of 322% and a CAGR of 15.5%

    60% confidence
  • VDE has outperformed EMLP on a 1-year total return basis (30.0% vs 21.4%) but has experienced a deeper maximum 5-year drawdown (-26.6% vs -14.6%)

    60% confidence
  • Motley Fool Stock Advisor's total average return is 892%, a market-crushing outperformance compared to 205% for the S&P 500

    60% confidence
  • VDE has generated a 10-year total return of 133%, equating to a CAGR of 8.8%

    60% confidence
  • EMLP is an actively managed fund focused on companies that generate at least half their revenue from energy infrastructure operations such as pipelines, storage tanks, and power transmission, which is why it carries higher costs

    60% confidence
  • Vanguard Energy ETF was not among the 10 best stocks identified by the Motley Fool Stock Advisor analyst team as of June 29, 2026

    60% confidence

Data points we hold from this source

S&P 500 Index Fund · cagr 10yr15.5 percent
S&P 500 Index Fund · total return 10yr322 percent
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,995
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,995 factos verificados com a fonte5,577 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Energy ETFs VDE and EMLP Differ on Cost and Approach — Source | Via News | pt.VIA.NEWS